Identification of Adverse Drug Event-Related Japanese Articles: Natural Language Processing Analysis

Shogo Ujiie1, Shuntaro Yada1, Shoko Wakamiya1

  • 1Nara Institute of Science and Technology, Nara, Japan.

JMIR Medical Informatics
|November 27, 2020
PubMed
Abstract

Insights

An automated system was developed to identify adverse drug events (ADEs) in medical articles, reducing manual labor for Japanese pharmaceutical companies. The system achieved high accuracy in document classification but requires improvement in sentence-level classification for real-world application.

Area of Science:

  • Pharmacovigilance
  • Natural Language Processing
  • Medical Informatics

Background:

  • Pharmaceutical companies systematically report adverse drug events (ADEs) for drug safety.
  • Recall-based reporting systems, like Japan's, can generate significant noise and false negatives due to broad ADE reporting requirements.
  • Manual labor for screening medical articles for ADEs is challenging and resource-intensive.

Purpose of the Study:

  • To develop an automated system for identifying ADE-related medical articles.
  • To support Japan's recall-based reporting system by efficiently screening literature.
  • To reduce the manual workload in Japanese pharmaceutical companies for drug safety surveillance.

Main Methods:

  • Utilized natural language processing (NLP) for automated medical article analysis.
  • Implemented document-level classification to identify articles containing ADEs.
  • Employed sentence-level classification to pinpoint specific sentences implying ADEs within articles.

Main Results:

  • Document-level classification achieved a high F1 score of 0.903.
  • Sentence-level classification yielded an F1 score of 0.413.
  • Performance was evaluated using 509 Japanese medical articles via fivefold cross-validation.

Conclusions:

  • A simple automated system can significantly alleviate manual labor in screening drug safety literature.
  • Improving sentence-level classification accuracy by incorporating broader context is a key future step.
  • The system is intended for application in real-world postmarketing surveillance to enhance drug safety monitoring.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.4K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.2K
Drug Nomenclature01:17

Drug Nomenclature

During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.7K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
10.5K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.3K